Unknown

Dataset Information

0

Gene Expression Characteristics of Liver Tissue Reveal the Underlying Pathogenesis of Hepatocellular Carcinoma.


ABSTRACT:

Background

Hepatocellular carcinoma (HCC) is high-mortality primary liver cancer and the most common malignant tumor in the world. This study is based on a hepatocellular carcinoma-related dysfunction module designed to explore the dysregulation of genes in liver cancer tissue.

Methods

By downloading the relevant data on the GEO database, we performed a differential analysis of healthy liver tissue and liver cancer tissues as well as healthy liver tissue and hepatocellular carcinoma tissue and then obtained two sets of differential genes and combined them. We performed a cointerpretation analysis of these differential genes and constructed related functional disorder modules. A hypergeometric test was performed to calculate the potential regulatory effects of multiple factors on the module, and a series of ncRNA and TF regulators were identified. We obtained a total of 4479 differentially expressed genes in hepatocellular carcinoma, and these genes were clustered into ten hepatocellular carcinoma-related functional interpretation disorder modules.

Results

Enrichment analysis revealed that these modular genes are mainly involved in signal transduction including cell cycle, TGF-beta signal transduction, and p53 signal transduction. Depending on the predictive analysis of multidimensional regulators, 323 ncRNAs and 52 TF-mediated hepatocellular carcinoma-related dysregulation modules were found to regulate disease progression.

Conclusions

Based on a series of investigations, it was found that miR-30b-5p may participate in the peroxisome signal transduction by downregulating ABCD3-mediated module 1, thereby promoting the development and progression of hepatocellular carcinoma. Our research results not only provide a theoretical basis for biologists to study hepatocellular carcinoma further but also offer new methods and new ideas for the personalized care and treatment of hepatocellular carcinoma.

SUBMITTER: Guo C 

PROVIDER: S-EPMC8506137 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC4937331 | biostudies-literature
| S-EPMC5228455 | biostudies-literature
| S-EPMC2856554 | biostudies-literature
| S-EPMC7834792 | biostudies-literature
| S-DIXA-D-1074 | biostudies-other
| S-EPMC6245377 | biostudies-literature
| S-EPMC10160086 | biostudies-literature
| S-EPMC4800979 | biostudies-literature
| S-EPMC9534058 | biostudies-literature
| S-EPMC7757567 | biostudies-literature